Barclays
CORZZ icon

Barclays’s Core Scientific Inc Tranche 2 Warrants CORZZ Stock Holding History

Barclays’s Portfolio CORZZ Stock Details CORZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50,000
Closed -$177K – 4941
2024
Q1 		$177K Buy
+50,000
New +$123K ﹤0.01% 4186

Other funds holding CORZZ

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
BCM
Bluefin Capital Management New York $156M AUM 18.47% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
HOWA
Heritage Oak Wealth Advisors Santa Rosa Beach, Florida $340M AUM 29.73% 1-Year Est. Return
SC
Seldon Capital San Francisco, California $272M AUM 90.68% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Barclays's CORZZ Position: Q2 2024 in Review

Barclays sold out of Core Scientific Inc Tranche 2 Warrants (CORZZ) in Q2 2024, closing a stake of 50,000 shares — an estimated $177K sold.

Barclays first reported a position in CORZZ in Q1 2024 and held it in 1 quarter. The position peaked at $177K in Q1 2024. 72 funds tracked by Wall St. Rank hold CORZZ as of Q2 2024.

  • Barclays reported no remaining Core Scientific Inc Tranche 2 Warrants position as of Q2 2024 after selling out during the quarter.
  • Barclays sold 50,000 Core Scientific Inc Tranche 2 Warrants shares in Q2 2024, an estimated $177K.
  • Barclays first reported a position in Core Scientific Inc Tranche 2 Warrants in Q1 2024 and held it in 1 quarter.
  • Barclays's Core Scientific Inc Tranche 2 Warrants position peaked at $177K in Q1 2024.
  • 72 funds tracked by Wall St. Rank held Core Scientific Inc Tranche 2 Warrants as of Q2 2024.

Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.